A phase I clinical and pharmacokinetic (PK) study with KahalalideF (KF) in patients (pts) with advanced solid tumors (AST) with a continuous weekly (W) 1-hour iv infusion schedule
- 1 November 2002
- journal article
- abstracts
- Published by Elsevier in European Journal Of Cancer
- Vol. 38, S33
- https://doi.org/10.1016/s0959-8049(02)80744-4
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: